Clinical trial
Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug…
NCT00362310 · Istituto Superiore di Sanità, Other · Completed
Key facts
| NCT number | NCT00362310 |
|---|---|
| Title | Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir |
| Official title | A Phase II Trial With the HIV Protease Inhibitor Indinavir for the Treatment of Classical Kaposi's Sarcoma |
| Lead sponsor | Istituto Superiore di Sanità, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Classical Kaposi's Sarcoma |
| Intervention type | Drug |
| Interventions | indinavir |
| Enrollment | 28 |
| Start date | Jun 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Aug 10, 2006 |
| Last update posted | Apr 14, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: